2012
DOI: 10.1038/ng.2388
|View full text |Cite
|
Sign up to set email alerts
|

A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation

Abstract: SNPs mapped to 8q24.21 have been shown to be associated with glioma development. By means of tag SNP genotyping/imputation, pooled next-generation sequencing (NGS) using long-range PCR, and subsequent validation SNP genotyping we identified seven low-frequency SNPs that were consistently and highly associated with glioma risk (p=10−25 to 10−14). The most associated SNP, rs55705857, remained highly significant after individual adjustment for the other top six and two previously published SNPs. After stratifying… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

8
115
2
1

Year Published

2012
2012
2021
2021

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 131 publications
(126 citation statements)
references
References 34 publications
(52 reference statements)
8
115
2
1
Order By: Relevance
“…In this regard, it is notable that the odds ratios (ORs) associated with rs55705857 G allele for all gliomas combined was markedly more elevated (per allele OR: ~3.1) than those reported for the SNPs tagging this locus (per allele ORs: 1.23-1.36) [3]. Strikingly, the excess risk associated with variant carrier status for this SNP in the report of Jenkins et al is on the order of five to six for oligodendroglial lineage gliomas and IDH1/2-mutant astrocytic gliomas, the most prominent risk association reported yet for a SNP identified through GWAS and subsequently validated through sequencing [7]. The minor allele frequency among people with these tumor types was 21%, compared with 5% in controls and approximately 3% in the general Caucasian population.…”
Section: Editorialmentioning
confidence: 56%
See 4 more Smart Citations
“…In this regard, it is notable that the odds ratios (ORs) associated with rs55705857 G allele for all gliomas combined was markedly more elevated (per allele OR: ~3.1) than those reported for the SNPs tagging this locus (per allele ORs: 1.23-1.36) [3]. Strikingly, the excess risk associated with variant carrier status for this SNP in the report of Jenkins et al is on the order of five to six for oligodendroglial lineage gliomas and IDH1/2-mutant astrocytic gliomas, the most prominent risk association reported yet for a SNP identified through GWAS and subsequently validated through sequencing [7]. The minor allele frequency among people with these tumor types was 21%, compared with 5% in controls and approximately 3% in the general Caucasian population.…”
Section: Editorialmentioning
confidence: 56%
“…show conclusively that the rs55705857 germline variant intronic to CCDC26 predicts acquisition of IDH1/2 mutations in gliomas, one of the few such genotype/phenotype relationships yet established [7]. It is not yet clear whether the rs55705857 G allele actually facilitates the development of IDH1/2 mutation or confers a selective advantage to cells that acquire such mutations.…”
Section: Editorialmentioning
confidence: 99%
See 3 more Smart Citations